STEALTH BIOTHERAPEUTICS CORP

c/o Intertrust Corporate Services (Cayman) Limited

190 Elgin Avenue

George Town, Grand Cayman

KY1-9005 Cayman Islands

July 8, 2020

VIA EDGAR SUBMISSION

Securities and Exchange Commission

Division of Corporation Finance

100 F Street, N.E.

Washington, D.C. 20549

 

Re:

Stealth BioTherapeutics Corp

    

Registration Statement on Form F-1

    

File No. 333-239356

    

Request for Acceleration

Ladies and Gentlemen:

Pursuant to Rule 461 promulgated under the Securities Act of 1933, as amended, Stealth BioTherapeutics Corp hereby requests acceleration of the effective date of its Registration Statement on Form F-1 (File No. 333-239356), so that it may become effective at 4:00 p.m., Eastern time, on July 10, 2020, or as soon as practicable thereafter.

 

Very truly yours,

 

STEALTH BIOTHERAPEUTICS CORP

By:   /s/ Irene P. McCarthy

Name:

Title:

 

Irene P. McCarthy

Chief Executive Officer